Lidocaine + Ketamine vs Paravertebral Block for Rib Fractures
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two methods for managing pain in individuals with rib fractures. Researchers aim to determine if a combination of lidocaine and ketamine infusions, a type of pain management therapy, is as effective as the more common paravertebral block. The goal is to control pain sufficiently to improve breathing and reduce the risk of pneumonia or the need for a ventilator. This trial suits those hospitalized with rib fractures who have not found relief with standard pain medications and are experiencing difficulty breathing or coughing. As an Early Phase 1 trial, this research focuses on understanding how the treatment works in people, offering participants the opportunity to be among the first to receive this innovative therapy.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Previous studies have shown that both lidocaine and ketamine infusions are safe for managing pain in patients with rib fractures. Research has demonstrated that these infusions can effectively reduce the need for other pain medications, which often have more side effects. Importantly, patients have tolerated these medications well when used individually.
Paravertebral blocks involve injecting a numbing medication like ropivacaine near the spinal nerves. Studies have found this method to be safe and effective for controlling pain in patients with rib fractures, helping manage pain without significant side effects.
While both treatments have shown safety individually, using lidocaine and ketamine together is relatively new for this specific purpose. The current trial aims to compare this combination to the established method of the paravertebral block. Safety data from these studies provide reassurance, but more research is needed to fully understand the safety of using lidocaine and ketamine together for rib fracture pain.12345Why are researchers excited about this trial's treatments?
Researchers are excited about these treatments because they offer new ways to manage pain from rib fractures. Unlike traditional methods that often rely on systemic pain relief, the lidocaine and ketamine infusion combo provides targeted relief by altering pain perception directly at the nervous system level. This could potentially offer more effective pain control with fewer side effects. On the other hand, the paravertebral block with ropivacaine works by delivering a local anesthetic directly near the nerves of the ribs, which may provide superior localized pain relief compared to systemic medications. These approaches could lead to faster recovery and less reliance on opioids, which is a significant advantage in pain management.
What evidence suggests that this trial's treatments could be effective for rib fracture pain?
This trial will compare two treatment options for managing pain from rib fractures: lidocaine and ketamine infusions, and paravertebral blocks with ropivacaine. Research has shown that paravertebral blocks with ropivacaine effectively manage pain from broken ribs, providing strong relief and serving as a reliable alternative to options like epidurals. Early evidence suggests that lidocaine and ketamine infusions are safe and might aid in pain control. Ketamine infusions have been successfully used for rib fracture pain. However, the combination of lidocaine and ketamine for this purpose is still under study, and more information is needed to determine their effectiveness compared to paravertebral blocks.12367
Are You a Good Fit for This Trial?
This trial is for adults aged 18-80 hospitalized with rib fractures who haven't had relief from standard pain treatments. It's not for those under 18 or over 80, pregnant women, patients with severe head injuries, spinal cord or serious pelvic injuries, those needing major surgery like laparotomy or thoracotomy during the stay, intubated patients at admission, or prisoners.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either paravertebral block with ropivacaine or simultaneous ketamine and lidocaine infusions for pain management
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessment of pain scores and opioid usage
What Are the Treatments Tested in This Trial?
Interventions
- Lidocaine and Ketamine Infusions
- N/A
- Paravertebral Block with Ropivacaine
Find a Clinic Near You
Who Is Running the Clinical Trial?
George Washington University
Lead Sponsor